A new scientific research has found new applications of anti-cancer drugs including the protection of patients from relapse after therapy.
More than the removal of tumor cells from the body, doctors working on cancer patients aim to provide a scenario that would prevent tumor cells from proliferating and causing a new disease.
The research was aimed at minimising the harm to the human body after the treatment of the deadly disease.
The study was published in the journal -- Journal for ImmunoTherapy of Cancer.
"In this study, we examined the cellular-level response of dendritic cells (immune system components) in their interaction with cancer cells that were exposed to photodynamic therapy (PDT) and proved that photodynamic therapy can activate the body's own immune response," said researcher Victoria Turubanova.
"The concept of immunogenic cell death (ICD) includes a programmed death of cancer cells with subsequent release of molecules that give a danger signal to the immune system. We tested the drugs that are already used in cancer therapy, and enhanced the action of these agents," said another researcher Professor Krys'ko.
The researchers examined additional aspects of the use of existing drugs for developing new cancer protocols based on the stimulation of the immune system. These variants of therapy help in reducing the risk of metastasis and also help in the patient's recovery.
Disclaimer: No Business Standard Journalist was involved in creation of this content
